Literature DB >> 25267439

Unaltered regulatory B-cell frequency and function in patients with multiple sclerosis.

Laure Michel1, Melanie Chesneau2, Philippe Manceau3, Athenais Genty3, Alexandra Garcia3, Marion Salou3, Annie Elong Ngono3, Annaïck Pallier2, Marylène Jacq-Foucher4, Fabienne Lefrère4, Sandrine Wiertlewski4, Jean-Paul Soulillou5, Nicolas Degauque5, David-Axel Laplaud6, Sophie Brouard7.   

Abstract

Multiple sclerosis (MS) is a chronic disease of the central nervous system (CNS) typically characterized by the recruitment of T cells into the CNS. However, certain subsets of B cells have been shown to negatively regulate autoimmune diseases and some data support a prominent role for B cells in MS physiopathology. For B cells in MS patients we analyzed subset frequency, cytokine secretion ability and suppressive properties. No differences in the frequencies of the B-cell subsets or in their ability to secrete cytokines were observed between MS and healthy volunteers (HV). Prestimulated B cells from MS patients also inhibited CD4(+)CD25(-) T cell proliferation with a similar efficiency as B cells from HV. Altogether, our data show that, in our MS patient cohort, regulatory B cells have conserved frequency and function.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  B cells; Multiple sclerosis; Regulation

Mesh:

Substances:

Year:  2014        PMID: 25267439     DOI: 10.1016/j.clim.2014.09.011

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  22 in total

1.  Circulating regulatory B cell subsets in patients with neuromyelitis optica spectrum disorders.

Authors:  Jinming Han; Li Sun; Zhongkun Wang; Xueli Fan; Lifang Wang; Yang-Yang Song; Jie Zhu; Tao Jin
Journal:  Neurol Sci       Date:  2017-04-07       Impact factor: 3.307

Review 2.  Circulating immune cells in multiple sclerosis.

Authors:  A P Jones; A G Kermode; R M Lucas; W M Carroll; D Nolan; P H Hart
Journal:  Clin Exp Immunol       Date:  2016-11-02       Impact factor: 4.330

Review 3.  Illuminating vitamin D effects on B cells--the multiple sclerosis perspective.

Authors:  Linda Rolf; Anne-Hilde Muris; Raymond Hupperts; Jan Damoiseaux
Journal:  Immunology       Date:  2016-02-02       Impact factor: 7.397

4.  Frequency and immunophenotype of IL10-producing regulatory B cells in optic neuritis.

Authors:  Sara Lundqvist; Signe Modvig; Emilie A Fischer; Jette L Frederiksen; Matilda Degn
Journal:  Immunology       Date:  2018-12-27       Impact factor: 7.397

Review 5.  Anti-B-Cell Therapies in Autoimmune Neurological Diseases: Rationale and Efficacy Trials.

Authors:  Harry Alexopoulos; Angie Biba; Marinos C Dalakas
Journal:  Neurotherapeutics       Date:  2016-01       Impact factor: 7.620

6.  The IL-10-producing regulatory B cells (B10 cells) and regulatory T cell subsets in neuromyelitis optica spectrum disorder.

Authors:  Eun Bin Cho; Hye-Jin Cho; Jin Myoung Seok; Ju-Hong Min; Eun-Suk Kang; Byoung Joon Kim
Journal:  Neurol Sci       Date:  2018-01-19       Impact factor: 3.307

Review 7.  Evolution of Anti-B Cell Therapeutics in Autoimmune Neurological Diseases.

Authors:  Panos Stathopoulos; Marinos C Dalakas
Journal:  Neurotherapeutics       Date:  2022-02-18       Impact factor: 6.088

Review 8.  Antigen Presentation, Autoantigens, and Immune Regulation in Multiple Sclerosis and Other Autoimmune Diseases.

Authors:  Christine Riedhammer; Robert Weissert
Journal:  Front Immunol       Date:  2015-06-17       Impact factor: 7.561

Review 9.  B Cells in the Multiple Sclerosis Central Nervous System: Trafficking and Contribution to CNS-Compartmentalized Inflammation.

Authors:  Laure Michel; Hanane Touil; Natalia B Pikor; Jennifer L Gommerman; Alexandre Prat; Amit Bar-Or
Journal:  Front Immunol       Date:  2015-12-24       Impact factor: 7.561

Review 10.  B Cells Are Multifunctional Players in Multiple Sclerosis Pathogenesis: Insights from Therapeutic Interventions.

Authors:  Nele Claes; Judith Fraussen; Piet Stinissen; Raymond Hupperts; Veerle Somers
Journal:  Front Immunol       Date:  2015-12-21       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.